Bioheaven360 Genotec & AIIMS Launch AI-Enabled Health Platform for Early Disease Detection

The platform leverages real-time machine learning algorithms that continuously improve diagnostic accuracy with each new dataset.

Biotechnology startup Bioheaven360 Genotec has partnered with the All India Institute of Medical Sciences (AIIMS), New Delhi, to launch an advanced AI-enabled health platform. 

The platform aims to improve early disease detection and facilitate personalized treatment planning.

The platform leverages real-time machine learning algorithms that continuously improve diagnostic accuracy with each new dataset. 

By integrating extensive phenotyping, it captures comprehensive patient data from multiple sources, including genetic information, lifestyle habits, biomarkers, and environmental factors.

Designed to support clinicians and individuals alike, the platform features cumulative risk assessments, AI-driven diagnostic tools, and adaptive self-learning capabilities that evolve based on incoming health data. 

This holistic approach is expected to enable more accurate risk profiling and tailored healthcare interventions.

Dr. Shailendra Vyas, Founder and CEO of Bioheaven360 Genotec, emphasized the platform’s patient-centric vision. 

“Our goal is to empower individuals with the knowledge and tools they need to make informed decisions about their health and well-being,” he said.

This collaboration marks a significant step forward in integrating artificial intelligence into India’s healthcare system. 

It has the potential to transform how chronic and complex diseases are identified and managed across diverse populations.

Stay tuned for more such updates on Digital Health News.